Global Plant-Based Active Pharmaceutical Ingredients (API) Market
Pharmaceuticals

Plant-Based Active Pharmaceutical Ingredients (API) Industry Anticipated to Expand at 6.6% CAGR During the Forecast Period

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

#What Is The Projected Market Size Of The Plant-Based Active Pharmaceutical Ingredients (API) Market By 2029?

The plant-based active pharmaceutical ingredients (API) market size has shown robust expansion in recent years. It is anticipated to grow from $30.22 billion in 2024 to $32.08 billion in 2025, reflecting a compound annual growth rate (CAGR) of 6.2%. This historical advancement can be ascribed to an uptick in traditional herbal medicine practices, a rising consumer preference for natural remedies, the development of early pharmaceutical formulations, the expansion of the global trade in medicinal herbs, and the increasing industrialization of botanical drugs.

The plant-based active pharmaceutical ingredients (API) market size is projected to experience robust expansion over the next few years, reaching $41.38 billion by 2029, with a compound annual growth rate (CAGR) of 6.6%. This anticipated growth during the forecast period stems from a growing consumer preference for natural medicines, increased investment in research for plant-based drugs, broader applications in managing chronic diseases, and enhanced collaborations between the pharmaceutical and botanical industries. Significant trends expected in this period involve artificial intelligence (AI)-driven drug discovery, sophisticated plant tissue culture techniques, precision fermentation for producing plant-derived compounds, and environmentally friendly extraction methods for sustainable manufacturing.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=23477&type=smp

Which Industry Drivers Are Expected To Accelerate The Plant-Based Active Pharmaceutical Ingredients (API) Market From 2025 To 2029?

The growing consumer preference for natural and organic products is projected to drive the expansion of the plant-based active pharmaceutical ingredients (API) market moving forward. Natural and organic products refer to items crafted from naturally sourced ingredients that are minimally processed and free from synthetic chemicals and genetically modified organisms (GMOs). This increasing consumer preference arises from growing health awareness and concerns over synthetic chemicals, as individuals become more conscious of the potential risks associated with artificial ingredients. Plant-based active pharmaceutical ingredients (APIs) support natural and organic products by offering effective, chemical-free medicinal benefits that align with consumer demand for clean, safe, and sustainable healthcare solutions. For instance, in May 2024, according to LETIS S.A., an Argentina-based organic products certification authority, organic food sales climbed to $61.67 billion in 2022, reflecting a 4.3% increase from the previous period, while other organic products added $5.906 billion to total sales, growing by 1.6%. Therefore, the increasing consumer preference for natural and organic products is fueling the growth of the plant-based active pharmaceutical ingredients (API) market.

What Are The Emerging Segments Gaining Attention In The Plant-Based Active Pharmaceutical Ingredients (API) Market?

The plant-based active pharmaceutical ingredients (api) market covered in this report is segmented –

1) By Product Type: Alkaloids, Glycosides, Cannabinoids, Flavonoid, Terpenes And Terpenoids, Polyphenols, Saponins, Other Product Types

2) By Source: Leaves, Roots, Bark, Flowers, Seeds, Fruits, Resin And Gums, Other Sources

3) By Distribution Channel: Online Retailers, Supermarkets Or Hypermarkets, Specialty Food Stores, Foodservice

4) By End-Use: Pharmaceuticals, Nutraceuticals, Herbal Based Industries, Other End-Uses

Subsegments:

1) Alkaloids: Morphine Alkaloids, Tropane Alkaloids, Quinolizidine Alkaloids, Indole Alkaloids, Isoquinoline Alkaloids, Pyrrolizidine Alkaloids

2) By Glycosides: Cardiac Glycosides, Anthraquinone Glycosides, Flavonoid Glycosides, Saponin Glycosides, Cyanogenic Glycosides

3) Cannabinoids: Tetrahydrocannabinol (THC), Cannabidiol (CBD), Cannabigerol (CBG), Cannabichromene (CBC), Cannabinol (CBN)

4) Flavonoid: Flavones, Flavonols, Isoflavones, Flavanones, Anthocyanins

5) Terpenes And Terpenoids: Monoterpenes, Sesquiterpenes, Diterpenes, Triterpenes, Tetraterpenes

6) Polyphenols: Phenolic Acids, Stilbenes, Lignans, Flavonoid Polyphenols

7) Saponins: Steroidal Saponins, Triterpenoid Saponins

8) Other Product Types: Coumarins, Tannins, Lignins, Phenolic Glycosides

What Trends Are Redefining The Plant-Based Active Pharmaceutical Ingredients (API) Market Dynamics?

Leading firms in the plant-based active pharmaceutical ingredients (API) sector are concentrating on creating novel offerings, such as plant-based squalene, to present sustainable and ethical substitutes for conventional animal-derived ingredients. Plant-based squalene offers an environmentally friendly and ethical option compared to squalene obtained from sharks, being derived from plants like amaranth, olives, and sugarcane for applications in pharmaceuticals, cosmetics, and vaccines. For example, in October 2023, Evonik Industries AG, a specialty chemicals company based in Germany, introduced PhytoSquene, which is the inaugural GMP-quality, plant-based squalene produced from amaranth oil. This innovation serves as a sustainable replacement for shark-derived squalene, guaranteeing high purity, consistent quality across batches, and adherence to European Pharmacopoeia (Ph. Eur.) standards. Squalene is vital in vaccine adjuvants, where it boosts immune responses. By providing a plant-based choice, PhytoSquene addresses concerns regarding biodiversity, lessens dependence on animal sources, and accommodates various cultural and religious needs.

Who Are The Top Performing Companies In The Plant-Based Active Pharmaceutical Ingredients (API) Market In Recent Years?

Major companies operating in the plant-based active pharmaceutical ingredients (API) market are Evonik Industries AG, Roquette Frères, Sun Pharmaceutical Industries Ltd, Aurobindo Pharma, Koninklijke DSM NV, Alembic Pharmaceuticals Ltd, Seppic, Indena SpA, PAI Pharma, Centroflora Group, Alkaloids Corporation, SCL Lifesciences Ltd, Alchem International Pvt Ltd, AMGIS Lifescience Ltd, C2 Pharma, PhytoHealth Corp, Bright Green Corporation, Sichuan Xieli Pharmaceutical Co Ltd, Brains Bioceutical Corp, Organotechnie, HimPharm.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/plant-based-active-pharmaceutical-ingredients-api-global-market-report

What Regional Growth Trends Are Shaping The Plant-Based Active Pharmaceutical Ingredients (API) Market Outlook?

North America was the largest region in the plant-based active pharmaceutical ingredients (API) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the plant-based active pharmaceutical ingredients (API) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Plant-Based Active Pharmaceutical Ingredients (API) Market Report:

https://www.thebusinessresearchcompany.com/customise?id=23477&type=smp

Browse Through More Reports Similar to the Global Plant-Based Active Pharmaceutical Ingredients (API) Market 2025, By The Business Research Company

Plant Factory Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/plant-factory-global-market-report

Plant Based Proteins Market 2025

https://www.thebusinessresearchcompany.com/report/plant-based-proteins-market

Plantbasedmeat Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/plantbasedmeat-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model